Search

Search Constraints

You searched for: Author/Creator Ronzoni, Monica

Search Results

1. A TCP-based early regression index predicts the pathological response in neo-adjuvant radio-chemotherapy of rectal cancer. Issue 3 (September 2018)

2. Accurate outcome prediction after neo-adjuvant radio-chemotherapy for rectal cancer based on a TCP-based early regression index. (November 2019)

4. Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the "CARACAS" study. (March 2023)

5. FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study. Issue 13 (October 2015)

6. Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial. (May 2021)

7. Predicting pathological response after radio-chemotherapy for rectal cancer: Impact of late oxaliplatin administration. (August 2020)

8. Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup Analysis. (13th January 2020)

9. Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer. (May 2014)

10. Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer. (May 2014)